InsidersTradesSigma
Track the AHE share price and the full insider trade history of the company, a publicly traded company based in Australia. Shares are listed on the AU market, under the oversight of ASX. Operating in the Health Care sector, AHE has published 2 reports. Market capitalisation: €10.8m. The latest transaction was filed on 31 July 2026 (Initial Substantial Holding). Among the most active insiders: Mercer Investments (Australia) Limited as Trustee of WSSP Australian Equities Trust. All data is free.
2
Insider Decl.
n/a
Thresholds
€3,990
1 ops.
Buy Volume
n/a
n/a
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,343 of 28,932 companies
24.4
score / 100
Value14
Quality35
FCF yld-14%
Earn yld-11%
EV/EBITDA·
ROE-178%
Gross mgn61%
Net mgn-0.1%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 31 July 2026
Declarations2 total
ShareASXASX:2924-03116926-6A1336818
323,541 shares@ A$0.020.0000% mcap100.0% of flowShareASXASX:2924-03089232-6A1325134
2 of 2 declarations
About AHE
AHE is a company operating in the healthcare and pharmaceutical sector. It is listed on the XASX market.